Darrington, D L <br/><br/>
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Dec 1994 
 - 2527-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1994.12.12.2527  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation--adverse effects<br/>Case-Control Studies<br/>Cohort Studies<br/>Combined Modality Therapy<br/>Female<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Hodgkin Disease--mortality<br/>Humans<br/>Incidence<br/>Leukemia, Myeloid, Acute--epidemiology<br/>Lymphoma, Non-Hodgkin--mortality<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--epidemiology<br/>Prognosis<br/>Radiotherapy Dosage<br/>Risk Factors<br/>Survival Rate<br/>Whole-Body Irradiation